IRF7 was shown to promote glioma cell invasion as well as chemoresistance and radiation resistance by inhibiting the expression of argonaute 2 (AGO2), a regulator of microRNA maturation, biosynthesis, and function (31). Here, AGO2 is linked to central nervous system cancer.